Publication|Videos|February 13, 2025
Implementing Diversity, Equity, and Inclusion in Drug Development
Jennifer Kim, PhD, assistant research professor, Tufts School of Medicine, Tufts Center for the Study of Drug Development, discusses barriers to participation for underrepresented populations in clinical trials and how Tufts is conducting research to better understand their nature.
Advertisement
Episodes in this series
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
What Patients Want from Remote Trials: New Survey Data Reveals Preferences Around Usability, Trust, and Participation
2
FDA Approves GSK’s Exdensur for Severe Asthma Based on SWIFT Phase III Data
3
ACT Brief: Patient Preferences in Remote Trials, Sanofi’s Neurology and Immunology Deals, and AI-Driven Biomarkers in Oncology
4
Rethinking Operational Models to Reduce Site Burden in 2026
5